43 min listen
Targeting Cancers with Gene Editing
Targeting Cancers with Gene Editing
ratings:
Length:
30 minutes
Released:
Jan 16, 2021
Format:
Podcast episode
Description
Certain aggressive cancers have profound effects on lifespan and quality of life. Patient prognosis can be grim, and therapies are harsh. Dr. Dan Peer of the University of Tel Aviv leads a group that has targeted gliomas and ovarian cancer with gene editing. Specifically, lipid nanoparticles are produced that target cancer cells, and introduce gene editing hardware that specifically inactivates genes required for cell division. The breakdown in proliferation impedes the cells’ growth. In animal models this single-treatment approach has shown benefit in increasing lifespan and presumably quality of life. We discuss the details of the technology and its potential translation to humans.Peer Lab Website Follow on Twitter: Peer_Lab# COLABRATalking Biotech is brought to you by Colabra – an R&D platform that brings your lab’s world-changing research together in one shared space. Learn more at https://www.colabra.app/# TALKING BIOTECHTwitter: https://twitter.com/talkingbiotechWebsite: https://www.colabra.app/podcasts/talking-biotech/Instagram: https://www.instagram.com/colabrahqThe Talking Biotech podcast is distinct from Dr. Kevin Folta's teaching and research roles at the University of Florida. The views expressed on the show are those of Dr. Folta and his guests, and do not reflect the opinions of the university or Colabra.
Released:
Jan 16, 2021
Format:
Podcast episode
Titles in the series (100)
Cherry Domestication and Breeding, Herbicide Beer?: Cherries are a perennial favorite fruit. However, they are a tree, so their genetic improvement is slow. Episode 27 features Dr. Amy Iezzoni, as she discusses cherry genetic origins and efforts to improve cherry through traditional breeding. In part by Talking Biotech with Dr. Kevin Folta